Clinical Trial Update: A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients with COPD During Exacerbations and When Stable

View source ↗

Summary

A pilot study to characterize FTIR spectral profiles in saliva and sputum of COPD patients during exacerbations and when stable has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Portsmouth Hospitals NHS Trust | Conditions: Chronic Obstructive Pulmonary Disease | Status: TERMINATED